92 related articles for article (PubMed ID: 30593750)
1. Overexpression of the mitochondrial ribosomal protein S18-2 in the invasive breast carcinomas.
Buchynska LG; Iurchenko NP; Kashuba EV; Brieieva OV; Glushchenko NM; Mints M; Lukianova NY; Chekhun VF
Exp Oncol; 2018 Dec; 40(4):303-308. PubMed ID: 30593750
[TBL] [Abstract][Full Text] [Related]
2. СD44+/CD24- markers of cancer stem cells in patients with breast cancer of different molecular subtypes.
Chekhun SV; Zadvorny TV; Tymovska YO; Anikusko MF; Novak OE; Polishchuk LZ
Exp Oncol; 2015 Mar; 37(1):58-63. PubMed ID: 25804234
[TBL] [Abstract][Full Text] [Related]
3. Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.
Incoronato M; Grimaldi AM; Cavaliere C; Inglese M; Mirabelli P; Monti S; Ferbo U; Nicolai E; Soricelli A; Catalano OA; Aiello M; Salvatore M
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1680-1693. PubMed ID: 29696443
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease.
Naleskina LA; Lukianova NY; Sobchenko SO; Storchai DM; Chekhun VF
Exp Oncol; 2016 Sep; 38(3):181-6. PubMed ID: 27685526
[TBL] [Abstract][Full Text] [Related]
5. Is there 'progression through grade' in ductal invasive breast cancer?
Schymik B; Buerger H; Krämer A; Voss U; van der Groep P; Meinerz W; van Diest PJ; Korsching E
Breast Cancer Res Treat; 2012 Oct; 135(3):693-703. PubMed ID: 22886478
[TBL] [Abstract][Full Text] [Related]
6. S18 family of mitochondrial ribosomal proteins: evolutionary history and Gly132 polymorphism in colon carcinoma.
Mushtaq M; Ali RH; Kashuba V; Klein G; Kashuba E
Oncotarget; 2016 Aug; 7(34):55649-55662. PubMed ID: 27489352
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors.
Kryzhanivska AE; Dyakiv IB; Kyshakevych I
Exp Oncol; 2018 Jun; 40(2):124-127. PubMed ID: 29949531
[TBL] [Abstract][Full Text] [Related]
8. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
9. Do MRPS18-2 and RB proteins cooperate to control cell stemness and differentiation, preventing cancer development?
Kashuba E; Mushtaq M
Exp Oncol; 2017 Mar; 39(1):12-16. PubMed ID: 28361860
[TBL] [Abstract][Full Text] [Related]
10. Preoperative MRI Evaluation of Axillary Lymph Nodes in Invasive Ductal Carcinoma: Comparison of Luminal A Versus Luminal B Subtypes in a Paradigm Using Ki-67 and Receptor Status.
Plaza MJ; Handa P; Esserman LE
AJR Am J Roentgenol; 2017 Apr; 208(4):910-915. PubMed ID: 28140614
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas.
Widodo I; Dwianingsih EK; Utoro T; Anwar SL; Aryandono T; Soeripto S
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2461-2467. PubMed ID: 30255700
[TBL] [Abstract][Full Text] [Related]
12. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
13. Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2.
Mushtaq M; Kovalevska L; Darekar S; Abramsson A; Zetterberg H; Kashuba V; Klein G; Arsenian-Henriksson M; Kashuba E
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15673-15683. PubMed ID: 32571933
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts.
Darekar SD; Mushtaq M; Gurrapu S; Kovalevska L; Drummond C; Petruchek M; Tirinato L; Di Fabrizio E; Carbone E; Kashuba E
Oncotarget; 2015 Aug; 6(25):21016-28. PubMed ID: 26023799
[TBL] [Abstract][Full Text] [Related]
15. Effect of Ki-67 on Immunohistochemical Classification of Luminal A to Luminal B Subtypes of Breast Carcinoma.
Cirqueira MB; Moreira MA; Soares LR; Cysneiros MA; Vilela MH; Freitas-Junior R
Breast J; 2015; 21(5):465-72. PubMed ID: 26138552
[TBL] [Abstract][Full Text] [Related]
16. Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases.
Strien L; Joensuu K; Heikkilä P; Leidenius MH
Anticancer Res; 2017 Jan; 37(1):175-182. PubMed ID: 28011488
[TBL] [Abstract][Full Text] [Related]
17. A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study.
Chaiwun B; Nakrungsee S; Sukhamwang N; Srisukho S
Breast Cancer; 2010; 17(1):35-41. PubMed ID: 19789946
[TBL] [Abstract][Full Text] [Related]
18. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.
Agresti R; Meneghini E; Baili P; Minicozzi P; Turco A; Cavallo I; Funaro F; Amash H; Berrino F; Tagliabue E; Sant M
Breast Cancer Res Treat; 2016 May; 157(1):179-89. PubMed ID: 27117160
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.
Bhargava R; Beriwal S; Striebel JM; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):113-8. PubMed ID: 19801938
[TBL] [Abstract][Full Text] [Related]
20. Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.
Gangadharan A; Nyirenda T; Patel K; Jaimes-Delgadillo N; Coletta D; Tanaka T; Walland AC; Jameel Z; Vedantam S; Tang S; Mannion C; Lee GY; Goy A; Pecora A; Suh KS
Breast; 2018 Jun; 39():101-109. PubMed ID: 29656222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
